Clinical Safety and Tolerability of Bifidobacterium bifidum BBi32: An 8‐Week Randomized, Double‐Blind, Placebo‐Controlled Trial With Genomic and In Vitro Corroboration

Documenti analoghi

• Probiotic Supplementation With Bifidobacterium longum Subsp. Longum BL21 Improves Glycemic Control and Modulates Gut Microbiota in Type 2 Diabetes: A Randomized Controlled Trial
  di: Chengsheng Zhu, et al.
  Pubblicazione: (2026)
• Safety and Tolerability of Withania somnifera Root Extract in Healthy Male Participants: A Pilot Randomized, Double‐Blind, Placebo‐Controlled Clinical Trial
  di: Narendra Vaidya, et al.
  Pubblicazione: (2025)
• Efficacy and Safety of Ecklonia cava Kjellman Extract Complex in Respiratory Health: A Randomized, Double‐Blind, Placebo‐Controlled, Multicenter Clinical Trial
  di: Seong‐Cheon Woo, et al.
  Pubblicazione: (2026)
• Characterization of Peptide Utilization by Bifidobacterium bifidum : Insights From Computer Simulations and In Vitro Verification to Enhance Nitrogen Source Utilization
  di: Xin Qian, et al.
  Pubblicazione: (2025)
• Impact of Probiotics Administration on the VEGF, Adiponectin, and Glycolipid Metabolism, in Prediabetic Patients: A Randomized, Double‐Blinded, Placebo‐Controlled Clinical Trial
  di: Mehrdad Sarabi, et al.
  Pubblicazione: (2025)